Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia.

Arihant JainAditya JandialThenmozhi ManiKamal KishoreCharanpreet SinghDeepesh LadGaurav PrakashAlka KhadwalReena DasNeelam VarmaSubhash VarmaPankaj Malhotra

Published in: Blood research (2024)

Our study revealed that the response rates of patients with AA and LD were similar to those of patients with SD to hATG combined with cyclosporine in a real-world setting.

Keyphrases

low dose
chronic kidney disease
high dose
early onset
single cell
allogeneic hematopoietic stem cell transplantation
type diabetes
metabolic syndrome
adipose tissue
acute lymphoblastic leukemia
combination therapy
smoking cessation